Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera

Paola Guglielmelli, Lorenzo Tozzi, Costanza Bogani, Ilaria Iacobucci, Vanessa Ponziani, Giovanni Martinelli, Alberto Bosi, Alessandro M. Vannucchi

Blood (2011) 117 (25): 6923–6927.

https://doi.org/10.1182/blood-2010-09-306506

Published: 2011

Includes: Supplemental data

Journal Articles

Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.

Paola Guglielmelli, MD, Lorenzo Tozzi, BSc, Vanessa Ponziani, PhD, Elisa Bianchi, PhD, Ilaria Iacobucci, PhD, Betty Giusti, PhD, Luciana Rossi, PhD, Giovanni Martinelli, MD, Rossella Manfredini, MD, Alberto Bosi, MD, Alessandro M. Vannucchi, MD

Blood (2009) 114 (22): 3896.

https://doi.org/10.1182/blood.V114.22.3896.3896

Published: 2009

Journal Articles

Changes of JAK2 V617F Allele Burden Over Time in Patients with Polycythemia Vera or Essential Thrombocythemia: A Retrospective Study of 172 Patients.

Elisabetta Antonioli, MD, Alessandra Carobbio, BStat, Lisa Pieri, MD, Alessandro Pancrazzi, BSc, Paola Guglielmelli, MD, Federica Delaini, BSc, Vanessa Ponziani, PhD, Maria Chiara Susini, MD, Rajmonda Fjerza, MD, Alberto Bosi, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD

Blood (2009) 114 (22): 1892.

https://doi.org/10.1182/blood.V114.22.1892.1892

Published: 2009

Journal Articles

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2 V617F mutated allele

Paola Guglielmelli, Giovanni Barosi, Giorgina Specchia, Alessandro Rambaldi, Francesco Lo Coco, Elisabetta Antonioli, Lisa Pieri, Alessandro Pancrazzi, Vanessa Ponziani, Federica Delaini, Giovanni Longo, Emanuele Ammatuna, Vincenzo Liso, Alberto Bosi, Tiziano Barbui, Alessandro M. Vannucchi

Blood (2009) 114 (8): 1477–1483.

https://doi.org/10.1182/blood-2009-04-216044

Published: 2009

Journal Articles

Clinical Relevance of JAK2 V617F Allele Burden in Primary and Post-Polycythemic/Post-Thrombocythemic Myelofibrosis

Paola Guglielmelli, MD, Giovanni Barosi, MD, Alessandro Pancrazzi, PhD, Giovanni Longo, MD, Elisabetta Antonioli, MD, Lisa Pieri, MD, Flavia Biamonte, BiSci, Vanessa Ponziani, PhD, Alessandro Rambaldi, Alberto Bosi, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD

Blood (2008) 112 (11): 2799.

https://doi.org/10.1182/blood.V112.11.2799.2799

Published: 2008

Journal Articles

Hypermethylation of CXCR4 Promoter, and Its Reactivation by Hypomethylating Agent, in CD34 + Cells from Primary Myelofibrosis Patients

Paola Guglielmelli, MD, Costanza Bogani, BiSc, Vanessa Ponziani, BiSc, Giada Poli, BiSc, Vittorio Rosti, MD, Cristophe Desterke, Alberto Bosi, MD, Marie Caroline Le Bousse-Kerdiles, PhD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD

Blood (2007) 110 (11): 1545.

https://doi.org/10.1182/blood.V110.11.1545.1545

Published: 2007

NARROW

Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera

Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.

Changes of JAK2 V617F Allele Burden Over Time in Patients with Polycythemia Vera or Essential Thrombocythemia: A Retrospective Study of 172 Patients.

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2 V617F mutated allele

Clinical Relevance of JAK2 V617F Allele Burden in Primary and Post-Polycythemic/Post-Thrombocythemic Myelofibrosis

Hypermethylation of CXCR4 Promoter, and Its Reactivation by Hypomethylating Agent, in CD34 + Cells from Primary Myelofibrosis Patients

Email alerts

ASH Publications

American Society of Hematology

Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera

Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.

Changes of JAK2 V617F Allele Burden Over Time in Patients with Polycythemia Vera or Essential Thrombocythemia: A Retrospective Study of 172 Patients.

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2 V617F mutated allele

Clinical Relevance of JAK2 V617F Allele Burden in Primary and Post-Polycythemic/Post-Thrombocythemic Myelofibrosis

Hypermethylation of CXCR4 Promoter, and Its Reactivation by Hypomethylating Agent, in CD34 + Cells from Primary Myelofibrosis Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only